Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Examining New and Old Anticoagulants and Their Effects

By Vanessa Caceres | on October 17, 2016 | 0 Comment
ACEP16
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

It’s normal to feel nervous if you are treating a patient with a gastrointestinal bleed who is on an anticoagulant. Yet there are different treatment paradigms when patients present with acute bleeding, and some of the newer anticoagulants could change current thinking, said Colin G. Kaide, MD, FACEP, associate professor of emergency medicine at the Wexner Medical Center at The Ohio State University in Columbus.

You Might Also Like
  • Low Risk of Brain Hemorrhage in Ground-Level Fall with Antiplatelets, Anticoagulants
  • ACEP15 Session: Treatment Update for Atrial Fibrillation
  • ACEP15 Session: Tips for Safer, More Efficient Ear Nose Throat Procedures
Explore This Issue
ACEP16 Tuesday Daily News
Dr. Kaide

Dr. Kaide

Dr. Kaide will focus on this topic during his session “Does All Bleeding Really Stop? Reversing New and Old Anticoagulants.”

The session will first provide attendees with a basic understanding of coagulation and anticoagulants. “I firmly believe that if you invest five or six minutes into understanding how the system works at a basic level, then everything else about reversal agents doesn’t have to be memorized. It can be derived from basic understanding,” he said.

Dr. Kaide will then go on to discuss strategies to reverse anticoagulation when patients use traditional medications such as warafin and heparin. The session will then cover some of the novel anticoagulation treatments, such as dabigatran, rivaroxaban, and apixaban.

The session also will address strategies for emergency physicians who don’t have access to newer agents.

The talk will include case-based scenarios and a discussion about the controversy over correcting numbers and bleeding and how they might actually reflect in outcomes. “We need to take a realistic understanding of what we can or can’t accomplish,” he said.


Vanessa Caceres is a freelance medical writer based in Florida.

Dr. Kaide
Rapid Fire: Does All Bleeding Really Stop? Reversing New and Old Anticoagulants
Tuesday, Oct. 18
12:30–12:55 p.m.
Mandalay Bay Ballroom D

Topics: ACEPACEP16American College of Emergency PhysiciansAnnual Scientific AssemblyAnticoagulantsBleeding DisordersEducationheparinWarafin

Related

  • Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment

    March 11, 2025 - 1 Comment
  • Reader Responds: Why Diversity, Equity, and Inclusion Matter in Medical Education

    October 9, 2024 - 0 Comment
  • Why Diversity, Equity, and Inclusion Matter in Medical Education

    August 13, 2024 - 3 Comments

Current Issue

ACEP Now: June 2025 (Digital)

Read More

No Responses to “Examining New and Old Anticoagulants and Their Effects”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603